Specialist

AXA IM has hired a sell-side healthcare specialist as the permanent replacement for former Health fund manager Gemma Game, who left the group last year.

Lessons from Silicon Valley's tech companies

Shell's planned £47bn takeover of BG Group could present ethical funds with a new dilemma as it removes one of their largest potential investments.

Aberdeen Asset Management is set to buy the remaining stake in its joint venture with SVG Capital, Aberdeen SVG Private Equity.

Woodford Investment Management, Ruffer, Sarasin and Invesco are among the groups backing a new share placing by Oakley Capital's private equity trust.

Investors are showing increasing willingness to pay for R&D pipelines in biotech, explains AXA Framlington's Linden Thomson.

With discounts on listed private equity trusts almost back to long-term averages, value in the sector can be hard to find. But Ben Williams, investment manager at Saunderson House, argues the improving merger and acquisition market is likely to benefit...

Edward Bramson's Sherborne Investors has further upped its interest in Electra Private Equity as it plans its next move following an unsuccessful attempt to take control of the trust last year.

Investment Week publisher Incisive Media has agreed a refinancing deal which sees private equity firm Alchemy Partners take a majority stake in the business.

With currency moves increasingly dominating financial headlines, Tilney Bestinvest's CIO has predicted hedging, not asset allocation, will be the key differentiator for investor returns next year.